Leonardo Lorente1, María M Martín2, Teresa Almeida3, Pedro Abreu-González4, José Ferreres5, Jordi Solé-Violán6, Lorenzo Labarta7, César Díaz8, Alejandro Jiménez9. 1. Intensive Care Unit, Hospital Universitario de Canarias, La Laguna, Santa Cruz de Tenerife, Spain. Electronic address: lorentemartin@msn.com. 2. Intensive Care Unit, Hospital Universitario Nuestra Señora de Candelaria, Santa Cruz de Tenerife, Spain. 3. Unidad de Genética, Instituto de Enfermedades Tropicales y Salud Pública de Canarias, Universidad de La Laguna, Campus de Anchieta, Avda, Astrofísico Francisco Sánchez s/n, La Laguna, Tenerife 38071, Spain. 4. Deparment of Phisiology, Faculty of Medicine, University of the La Laguna, Santa Cruz de Tenerife, Spain. 5. Intensive Care Unit, Hospital Clínico Universitario de Valencia, Valencia, Spain. 6. Intensive Care Unit, Hospital Universitario Dr. Negrín, Las Palmas de Gran Canaria, Spain. 7. Intensive Care Unit, Hospital San Jorge de Huesca, Huesca, Spain. 8. Intensive Care Unit, Hospital Insular, Las Palmas de Gran Canaria, Spain. 9. Research Unit, Hospital Universitario de Canarias, La Laguna, Santa Cruz de Tenerife, Spain.
Abstract
PURPOSE: Total antioxidant capacity (TAC) in severe septic patients has been analyzed in few studies with limited number of subjects. In addition, no association between TAC serum levels and mortality in patients with sepsis has been investigated. We aimed at assessing a possible relationship between TAC serum levels and mortality using a large cohort of patients with severe sepsis. METHODS: We performed an observational, prospective, multicenter study in 6 Spanish intensive care units. Serum levels of TAC were measured in a total of 213 patients with severe sepsis. End point was 30-day mortality. RESULTS: Nonsurviving septic patients (n = 75) showed higher serum TAC levels (P = .006) than survivors (n = 138). Cox regression analysis showed that TAC serum levels were associated with 30-day survival (hazard ratio = 1.50, 95% confidence interval = 1.16-1.94, P = .002). Receiver operating characteristic analysis showed that the area under curve of TAC serum levels to predict 30-day survival was 0.61 (95% confidence interval = 0.545-0.680, P = .04). CONCLUSIONS: The most relevant and new findings of our study, the largest cohort of septic patients providing data on circulating TAC levels so far, were that serum TAC levels are associated with mortality and could be used as biomarker to outcome prediction in severe septic patients.
PURPOSE: Total antioxidant capacity (TAC) in severe septicpatients has been analyzed in few studies with limited number of subjects. In addition, no association between TAC serum levels and mortality in patients with sepsis has been investigated. We aimed at assessing a possible relationship between TAC serum levels and mortality using a large cohort of patients with severe sepsis. METHODS: We performed an observational, prospective, multicenter study in 6 Spanish intensive care units. Serum levels of TAC were measured in a total of 213 patients with severe sepsis. End point was 30-day mortality. RESULTS: Nonsurviving septicpatients (n = 75) showed higher serum TAC levels (P = .006) than survivors (n = 138). Cox regression analysis showed that TAC serum levels were associated with 30-day survival (hazard ratio = 1.50, 95% confidence interval = 1.16-1.94, P = .002). Receiver operating characteristic analysis showed that the area under curve of TAC serum levels to predict 30-day survival was 0.61 (95% confidence interval = 0.545-0.680, P = .04). CONCLUSIONS: The most relevant and new findings of our study, the largest cohort of septicpatients providing data on circulating TAC levels so far, were that serum TAC levels are associated with mortality and could be used as biomarker to outcome prediction in severe septicpatients.
Authors: Leonardo Lorente; María M Martín; Antonia Pérez-Cejas; Pedro Abreu-González; Luis Ramos; Mónica Argueso; Juan J Cáceres; Jordi Solé-Violán; Alejandro Jiménez Journal: Ann Intensive Care Date: 2016-04-23 Impact factor: 6.925
Authors: Sebastián P Chapela; Isabel Burgos; Christian Congost; Romina Canzonieri; Alexis Muryan; Manuel Alonso; Carlos A Stella Journal: Oxid Med Cell Longev Date: 2018-11-06 Impact factor: 6.543
Authors: Julia Masomi-Bornwasser; Elena Kurz; Christina Frenz; Jan Schmitt; Dominik M A Wesp; Jochem König; Johannes Lotz; Florian Ringel; Thomas Kerz; Harald Krenzlin; Naureen Keric Journal: Biomolecules Date: 2021-11-01
Authors: Camila Peres Rubio; Josefa Hernández-Ruiz; Silvia Martinez-Subiela; Asta Tvarijonaviciute; José Joaquin Ceron Journal: BMC Vet Res Date: 2016-08-15 Impact factor: 2.741